Journals / Dicle Tıp Dergisi / 2014 / Cilt: 41 - Sayı: 3

Serum vitamin D seviyelerinin fibromiyalji sendromunun klinik bulguları ile ilişkisi

The relation between serum vitamin D levels and clinical findings of fibromyalgia syndrome

Pages
446–450
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: It was concluded that 25-OH vitamin D deficiency may be related to the clinical findings such as widespread body pain, depression, headache and sleep disorder in patients with FMS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study was performed to identify serum 25-OH vitamin D levels and to investigate the relationship between 25-OH vitamin D and clinical findings on patients with fibromyalgia syndrome (FMS).
📊
Key Findings & Data:Methods: Nineteen premenopausal women with FMS who were diagnosed according to ACR 1990 fibromyalgia diagnostic criteria and 24 premenopausal healthy women as control group were included in the study.
💡
Conclusion & Impact:Conclusion: It was concluded that 25-OH vitamin D deficiency may be related to the clinical findings such as widespread body pain, depression, headache and sleep disorder in patients with FMS.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: This study was performed to identify serum 25-OH vitamin D levels and to investigate the relationship between 25-OH vitamin D and clinical findings on patients with fibromyalgia syndrome (FMS). Methods: Nineteen premenopausal women with FMS who were diagnosed according to ACR 1990 fibromyalgia diagnostic criteria and 24 premenopausal healthy women as control group were included in the study. Serum 25-OH vitamin D levels were determined in both patient and control groups. Widespread body pain, headache, fatigue, morning stiffness, sleep disorder, the number of tender points, Fibromyalgia Impact Questionnaire (FIQ) scores and Beck depression scores were evaluated as clinical findings in patients with FMS. Results: Serum 25-OH vitamin D levels were significantly lower in patients with FMS than those in control group (p=0.01). There were significantly negative correlations between 25-OH vitamin D levels and widespread body pain (r=-0.731), Beck depression scores (r=-0.777), headache (r=-0.629), and sleep disorder (r=-0.767) in the FMS group (p<0.01). Conclusion: It was concluded that 25-OH vitamin D deficiency may be related to the clinical findings such as widespread body pain, depression, headache and sleep disorder in patients with FMS.

Özet

Amaç: Bu çalışma, fibromiyalji sendromlu (FMS) hastalarda serum 25-OH vitamin D seviyelerini belirlemek ve 25-OH vitamin D seviyelerinin klinik bulgular ile ilişkisini araştırmak amacıyla yapıldı. Yöntemler: Çalışmaya ACR 1990 fibromiyalji tanı kriterlerine göre tanı konulan ondokuz premenapozal kadın ve kontrol grubu olarak 24 premenapozal sağlıklı kadın dahil edildi. Yaygın vücut ağrısı, baş ağrısı, yorgunluk, sabah tutukluğu, uyku bozukluğu, hassas nokta sayısı, fibromiyalji etki anketi skorları ve Beck depresyon skorları FMSnin klinik bulguları olarak değerlendirildi. Bulgular: Serum 25-OH vitamin D seviyeleri FMSli hastalarda kontrol grubuna göre anlamlı olarak daha düşüktü (p=0.01). FMS grubunda 25-OH vitamin D seviyeleri ile yaygın vücut ağrısı (r=-0.731), Beck depresyon skorları (r=-0.777), baş ağrısı (r=-0.629) ve uyku bozukluğu arasında (r=-0.767) anlamlı negatif korelasyonlar vardı (p<0.01). Sonuç: 25-OH vitamin D eksikliğinin FMSnin yaygın vü- cut ağrısı, depresyon, baş ağrısı ve uyku bozukluğu gibi klinik bulguları ile ilişkili olabileceği değerlendirildi.

🔖

Cite This Article

BAYGUTALP, N. K., BAYGUTALP, F., ŞEFEROĞLU, B., BAKAN, E. (2014). Serum vitamin D seviyelerinin fibromiyalji sendromunun klinik bulguları ile ilişkisi. Dicle Tıp Dergisi, Cilt: 41 - Sayı: 3, 446–450. https://ajindex.com/articles/349692

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Gupta A, Silman AJ. Psychological stress and fibromyalgia: a review of the evidence suggesting a neuroendocrine link. Arthritis Res Ther 2004;6:98-106
  2. Marder WD, Meenan RF, et al.The present and future adequacy or heumatologyman power. A study of health care needs and physician supply. Arthritis Rheum 1991;34:1209-1217
  3. Abeles AM, Pillinger MH, Solitar BM, Abeles M. Narrative review: the pathophysiology of fibromyalgia. Ann Intern Med 2007;146:726-734
  4. Gur A. Etiopathogenesis in Fibromyalgia. Turk J Phys Med Rehab 2008;54:4-11
  5. Dessein PH, Shipton EA, Joffe BI, et al. Hyposecretion of adrenal androgens and the relation of serum adrenal steroids, serotonin and insulin-like growth factor-1 to clinical features in women with fibromyalgia. Pain 1999;83:313- 319
  6. Senel K, Baygutalp F, Baykal T, et al. Melatonin levels in premenopausal women with fibromyalgia syndrome. Rheumatol Int 2013;33:1609-1610
  7. Karatay S, Yıldırım K, Melikoglu MA, Senel K. The relationship of endocrine hormone levels and clinical parameters in the young patients with fibromyalgia. J PM&R 2003;3:117-120
  8. Bhatty SA, Shaikh NA, Irfan M et al. Vitamin D deficiency in fibromyalgia. J Pak Med Assoc 2010;60:949-951
  9. KilicBaygutalp, Seferoglu B, Baygutalp F, Senel K. The correlation of serum prolactin levels and clinical parameters in the patients with fibromyalgia syndrome. J PMR Sci 2013;16:83-87
  10. Burckhardt CS, Clark SR, Bennett RM. The Fibromiyalgia Impact Questionnaire: developmentand validation. J Rheumatol 1991;18:728-733
  11. Sarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 2000;20:9-12
  12. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia Arthritis Rheum 1990;33:160-172
  13. Ulusoy M, Sahin N, Erkmen H. Turkish version of the Beck Anxiety Inventory. Psychometric properties. J Cognit Psychother1996;46:125-132
  14. Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev 1988;8:77-100
  15. Chapman CR, Casey KL, Dubner R, et al. Pain measurement: an overview. Pain 1985;22:1-31
  16. Lequesne MG, Mery C, Samson M, Gerard P. Indexes of severity for osteoarthritis of the hip and knee. Scand J Rheumatol Suppl 1987;65:85-89
  17. Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh Sleep Quality Index: A new instrument f